Bordetella pertussis Isolates with a Heterogeneous Phenotype for Erythromycin Resistance
Authors:
- 1 August 2002
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 40 (8) , 2942-2944
Abstract
Erythromycin is currently being used for both prophylaxis and treatment of pertussis infections. Erythromycin resistance was first recognized in Bordetella pertussis in Arizona in 1994, and since then, three additional resistant isolates have been identified in the United States. To better assess the potential public health impact of erythromycin-resistant B. pertussis , we used the disk diffusion assay to evaluate the frequency of erythromycin resistance among 1,030 recently circulating U.S. isolates and found the rate of occurrence to be B. pertussis isolates and their potential association with changing pertussis epidemiology.Keywords
This publication has 7 references indexed in Scilit:
- Changes in Predominance and Diversity of Genomic Subtypes of Bordetella pertussis Isolated in the United States, 1935 to 1999Emerging Infectious Diseases, 2002
- PROGRESSIVE RESPIRATORY DISTRESS IN AN INFANT TREATED FOR PRESUMED PERTUSSISThe Pediatric Infectious Disease Journal, 2000
- TUBERCULOSIS-ASSOCIATED HEMOPHAGOCYTIC SYNDROME IN AN INFANTThe Pediatric Infectious Disease Journal, 2000
- A Simplified Method for Testing Bordetella pertussis for Resistance to Erythromycin and Other Antimicrobial AgentsJournal of Clinical Microbiology, 2000
- Comparison of three media for agar dilution susceptibility testing ofBordetella pertussis using six antibioticsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1998
- Surveillance and detection of erythromycin resistance in Bordetella pertussis isolates recovered from a pediatric population in the Intermountain West region of the United StatesJournal of Clinical Microbiology, 1997
- Pertussis caused by an erythromycin-resistant strain of Bordetella pertussisThe Pediatric Infectious Disease Journal, 1995